FDA inspection
Ipsen Pharma Biotech: FDA inspection ending Jun 24, 2014
FDA inspection 886713 · Voluntary Action Indicated (VAI) · Signes
Key facts
| Inspection ID | 886713 |
|---|---|
| Firm | Ipsen Pharma Biotech |
| FEI number | 3003749112 |
| Address | Chemin Departemental, 402 Parc Activite Plateau Signes |
| City | Signes |
| Country | France |
| Fiscal year | 2014 |
| Inspection end date | Jun 24, 2014 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data